Fig. 1From: Vedolizumab trough level monitoring in inflammatory bowel disease: a state-of-the-art overviewSWOT analysis (strengths, weaknesses, opportunities and threats) summarizing the promising features and potential drawbacks of vedolizumab trough level monitoring in inflammatory bowel disease (IBD). PK/PD: pharmacokinetic/pharmacodynamic; TDM: therapeutic drug monitoringBack to article page